Yoshihito Nagura

The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis

Sho Matoya, Takanori Suzuki, Kentaro Matsuura et al. · Hepatology Research · 2023 · 22 citations · Full text

Medicine, Oncology, Pharmacology +14

The first management using intubation of a nasogastric tube with Gastrografin enterography or long tube for non-strangulated acute small bowel obstruction: a multicenter, randomized controlled trial

Takahito Katano, Takaya Shimura, Hirotada Nishie et al. · Journal of Gastroenterology · 2020 · 15 citations

Medicine, Clinical Sciences, Internal Medicine +15

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection

Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura et al. · PLoS ONE · 2021 · 12 citations · Full text

Medicine, Immunology, Oncology +14

Percutaneous Transhepatic Self-expanding Metallic Stent Placement for the Treatment of Malignant Afferent Loop Obstruction

Naruomi Jinno, Itaru Naitoh, Yoshihito Nagura et al. · Internal Medicine · 2017 · 11 citations · Full text

Medicine, Radiology, Surgery +17

Long‐term outcomes of nasogastric tube with Gastrografin for adhesive small bowel obstruction

Hirotada Nishie, Takaya Shimura, Takahito Katano et al. · Journal of Gastroenterology and Hepatology · 2021 · 11 citations

Medicine, Clinical Sciences, Surgery +17